Everyone is entitled to their opinion and beliefs Mayo, including Tim & myself. So just what offer price do you think would get the nod from PLS's BOD right now if any predators were interested? AFR would probably agree that a lucrative markup of 66% should easily do the job, which means a bid of around $6.60 would be successful. I would have thought holders would not be happy with that low figure considering all the pros & cons?
BTW, by doing my own research & ignoring journos, AFR, GS and other self proclaimed experts, as a long term investor (non-trader) I've managed to grow my lithium investments from a mere $6k in 2014 to over $1M now. I fully expect my current strategies to double that figure over the coming 2 years and even more in the future. If media articles were heeded, this wouldn't have been possible. BTW, the CR you expect is not likely, unless one believes media news over BOD advice. Lets just see where this ends up and who is correct, hey?
- Forums
- ASX - By Stock
- PLS
- Good News & Bad News
Good News & Bad News, page-26511
-
-
- There are more pages in this discussion • 17,882 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.02 |
Change
0.000(0.00%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
0.0¢ | $3.11 | $3.02 | $448.9K | 119.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2297 | $3.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.87 | 13668 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2297 | 3.260 |
3 | 23496 | 3.170 |
1 | 924 | 3.160 |
1 | 4006 | 3.120 |
3 | 6014 | 3.110 |
Price($) | Vol. | No. |
---|---|---|
2.870 | 7397 | 6 |
2.880 | 1107 | 1 |
2.930 | 86633 | 19 |
2.940 | 34259 | 1 |
2.950 | 5000 | 1 |
Last trade - 10.00am 16/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online